---
category: news
title: "BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence"
excerpt: "BioMarin will receive an exclusive option to obtain Deep Genomics' rights to each program for development and commercialization. In the collaboration, Deep Genomics will use its AI Workbench to identify and validate target mechanisms and lead candidates,"
publishedDateTime: 2020-11-17T13:29:00Z
originalUrl: "https://www.nasdaq.com/press-release/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using"
webUrl: "https://www.nasdaq.com/press-release/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using"
type: article
quality: 30
heat: -1
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI

related:
  - title: "BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence"
    excerpt: "In the collaboration, Deep Genomics will use its AI Workbench to identify and validate target mechanisms and lead candidates, and BioMarin will advance them into preclinical and clinical development."
    publishedDateTime: 2020-11-17T17:26:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    ampWebUrl: "https://markets.businessinsider.com/amp/news/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    cdnAmpWebUrl: "https://markets-businessinsider-com.cdn.ampproject.org/c/s/markets.businessinsider.com/amp/news/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 52
  - title: "Deep Genomics hits the partnering ground running with BioMarin deal"
    excerpt: "Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer to ramp up its partnering game, it’s unveiling its first biopharma tie-up: BioMarin. The duo will use the Toronto biotech’s artificial-intelligence-based drug discovery platform to discover new drugs for rare diseases."
    publishedDateTime: 2020-11-17T12:30:00Z
    webUrl: "https://www.fiercebiotech.com/medtech/deep-genomics-hits-partnering-ground-running-biomarin-deal"
    type: article
    provider:
      name: FierceBiotech
      domain: fiercebiotech.com
    quality: 24
    images:
      - url: "https://qtxasset.com/fiercebiotech/1605581585/business-3167295_1920.jpg/business-3167295_1920.jpg?6hcgAYGOAWuchq3deRZ84GvtFYN5dzAC"
        width: 1920
        height: 1280
        isCached: true

secured: "z/pSG9xth4MoyUsZ7f8WWxoBjlfZSDi3uqVzEb7B1eG51Kpt4b+vqpbEQWHSytkAW/0wcfJPTHXsxPUNMDYiyDRZ44mDquQUwbHKhF66nIjx4QPJplBf3rl5mWlEwtPhfgIYacTIEdhLujNoNbseyB4fS/glTcUgIMmRcR3JN9gCCLWEPQQhW1f04e05THCxaPL7FDmnb9MhTi9UzyiOsLlTKJb9BpG1EQNbXjYLRItMwYG0gkcYOjvNl/vw6nGlRoTedKTTQyvi9SPOcVj+ACCbyapVmNg4pKipW4UFbzNOUjZMOlrJKGnvqpB9+a9bHuRUpFjt/sJr9qQ7vJz5r8nUQik95e3thtWruKKZAD4=;G1FgQLZewLYj4oKus9S0Vw=="
---

